X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (466) 466
Patent (112) 112
Publication (55) 55
Magazine Article (11) 11
Book Chapter (3) 3
Book / eBook (2) 2
Conference Proceeding (2) 2
Book Review (1) 1
Dissertation (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (155) 155
female (141) 141
index medicus (124) 124
male (118) 118
middle aged (116) 116
aged (107) 107
adult (106) 106
oncology (106) 106
physics (71) 71
treatment outcome (63) 63
aged, 80 and over (62) 62
cancer (57) 57
advertising (53) 53
arrangements or circuits for control of indicating devicesusing static means to present variable information (53) 53
cryptography (53) 53
display (53) 53
education (53) 53
seals (53) 53
article (50) 50
neoplasms - drug therapy (50) 50
young adult (50) 50
mutation (46) 46
adolescent (41) 41
antineoplastic combined chemotherapy protocols - therapeutic use (41) 41
electricity (41) 41
clinical trials (36) 36
solid tumors (36) 36
antineoplastic combined chemotherapy protocols - adverse effects (34) 34
pharmacology & pharmacy (32) 32
medicine & public health (29) 29
research (29) 29
chemotherapy (28) 28
disease-free survival (28) 28
bevacizumab (27) 27
care and treatment (27) 27
generation (27) 27
pharmacology/toxicology (27) 27
conversion or distribution of electric power (26) 26
neoplasms - genetics (26) 26
retrospective studies (26) 26
neoplasms - pathology (24) 24
patients (23) 23
prognosis (22) 22
survival (22) 22
antineoplastic agents - therapeutic use (21) 21
maximum tolerated dose (21) 21
tumors (21) 21
antineoplastic combined chemotherapy protocols - administration & dosage (20) 20
devices or arrangements, the optical operation of which ismodified by changing the optical properties of the medium of thedevices or arrangements for the control of the intensity,colour, phase, polarisation or direction of light, e.g.switching, gating, modulating or demodulating (20) 20
frequency-changing (20) 20
non-linear optics (20) 20
optical analogue/digital converters (20) 20
optical logic elements (20) 20
optics (20) 20
techniques or procedures for the operation thereof (20) 20
kaplan-meier estimate (19) 19
child (18) 18
metastasis (18) 18
neoplasm metastasis (18) 18
phosphatidylinositol 3-kinases - genetics (18) 18
protein kinase inhibitors - therapeutic use (18) 18
clinical trials, phase i as topic (17) 17
drug therapy (17) 17
neoplasms (17) 17
phase i (17) 17
analysis (16) 16
dose-response relationship, drug (16) 16
calculating (15) 15
cancer patients (15) 15
cell lung-cancer (15) 15
class i phosphatidylinositol 3-kinases (15) 15
computing (15) 15
counting (15) 15
neoplasms - metabolism (15) 15
neoplasms - mortality (15) 15
phase i trial (15) 15
studies (15) 15
therapy (15) 15
toxicity (15) 15
colorectal cancer (14) 14
liver neoplasms - secondary (14) 14
ovarian cancer (14) 14
ovarian neoplasms - drug therapy (14) 14
colorectal-cancer (13) 13
complications and side effects (13) 13
liver neoplasms - drug therapy (13) 13
neoplasm staging (13) 13
research paper (13) 13
resistance (13) 13
survival rate (13) 13
tor serine-threonine kinases - antagonists & inhibitors (13) 13
angiogenesis (12) 12
antibodies, monoclonal, humanized - administration & dosage (12) 12
antimitotic agents (12) 12
antineoplastic agents (12) 12
antineoplastic agents - pharmacology (12) 12
breast-cancer (12) 12
genetic aspects (12) 12
lung-cancer (12) 12
melanoma (12) 12
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Oncology, ISSN 0732-183X, 02/2013, Volume 31, Issue 6, pp. 818 - 818
Journal Article
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 03/2017, Volume 23, Issue 6, pp. 1388 - 1396
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 2011, Volume 6, Issue 7, p. e22769
Journal Article
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 01/2018, Volume 24, Issue 1, pp. 181 - 188
Journal Article
Molecular Cancer Therapeutics, ISSN 1535-7163, 03/2018, Volume 17, Issue 3, pp. 671 - 676
Preclinical data suggest that combining a checkpoint inhibition with immunomodulatory derivative can increase anticancer response. We designed a... 
MULTIPLE-MYELOMA | APOPTOSIS | MALIGNANCY | MELANOMA | THERAPY | ONCOLOGY | LYMPHOMA | BLOCKADE | NIVOLUMAB | FAILURE | Thrombocytopenia | Anemia | Toxicity | Immunomodulation | Exanthema | Melanoma | Pancreatitis | Shrinkage | Patients | Lymphoma | CTLA-4 protein | Thyroid cancer | Pneumonitis | Hypopituitarism | Safety engineering | Lymphomas | Mutation | Toxic diseases | Thromboembolism | Hodgkin's disease | Cancer | Thyroid
Journal Article
Investigational New Drugs, ISSN 0167-6997, 8/2018, Volume 36, Issue 4, pp. 638 - 646
Background Immunotherapy is emerging as the cornerstone for treatment of patients with advanced cancer, but significant toxicity (immune-related adverse events... 
Response | Checkpoint inhibitors | Medicine & Public Health | Immunotherapy | Systemic steroids | Time to progression | Oncology | Pharmacology/Toxicology | Immune-related adverse event | LYMPHOCYTE | ANTIBODY | METASTATIC MELANOMA | PEMBROLIZUMAB | TOXICITIES | ONCOLOGY | LONG-TERM SAFETY | PHARMACOLOGY & PHARMACY | NIVOLUMAB | CLINICAL-RESPONSE | IPILIMUMAB | Humans | Middle Aged | Risk Factors | Immunologic Factors - immunology | Antibodies, Monoclonal - therapeutic use | Male | Treatment Outcome | Immunotherapy - adverse effects | Incidence | Young Adult | Neoplasms - therapy | Neoplasms - immunology | Aged, 80 and over | Adult | Female | Aged | Retrospective Studies | Antibodies, Monoclonal - immunology | Adrenal Cortex Hormones - administration & dosage | Treatment outcome | Care and treatment | Usage | Analysis | Medical records | Development and progression | Diagnosis | Research | Cancer | Immune system | Corticoids | Corticosteroids | Toxicity | Medical services | Lymphocytes T | Immune status | Enterocolitis | Risk analysis | Dermatitis | Patients | Electronic medical records | Clinical outcomes | Risk factors | Studies | Medical electronics | Electronic health records | Index Medicus | systemic steroids | time to progression | response | checkpoint inhibitors | immunotherapy | immune-related adverse event
Journal Article